AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33707989 — intervention group
Group type: EXPERIMENTAL
Intervention: Head cooling (HC)
Number of subjects: 10
Study 33707989 — intervention group
Group type: COMPARATOR
Intervention: No cooling (CON)
Number of subjects: 10
Study 34709134 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity plyometric training for 7 weeks
Number of subjects: 28
Study 34709134 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study 33392842 — intervention group
Group type: EXPERIMENTAL
Intervention: DE-assisted wide local excision
Number of subjects: 78
Study 33392842 — intervention group
Group type: COMPARATOR
Intervention: Standard wide local excision (no-DE)
Number of subjects: 78
Study 35343901 — intervention group
Group type: EXPERIMENTAL
Intervention: High level of effort for behavioral adherence
Number of subjects: 947
Study 35343901 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate level of effort for attitudinal adherence
Number of subjects: 947
Study 35343901 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence measures in initiators-only sample
Number of subjects: 947
Study 34563097 — intervention group
Group type: EXPERIMENTAL
Intervention: Human recombinant epidermal growth factor (h‐EGF) in 2% carboxymethyl cellulose gel
Number of subjects: 25
Study 34563097 — intervention group
Group type: COMPARATOR
Intervention: 2% carboxymethyl cellulose gel (control)
Number of subjects: 25
Study 34654942 — intervention group
Group type: EXPERIMENTAL
Intervention: GI-0.025 mL
Number of subjects: 30
Study 34654942 — intervention group
Group type: EXPERIMENTAL
Intervention: GII-0.05 mL
Number of subjects: 30
Study 34654942 — intervention group
Group type: EXPERIMENTAL
Intervention: GIII-0.10 mL
Number of subjects: 30
Study 34147439 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary CTA-guided group (n=200)
Number of subjects: 400
Study 34147439 — intervention group
Group type: COMPARATOR
Intervention: Angiography-guided group (n=200)
Number of subjects: 400
Study 32243582 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (5-HT reuptake inhibitor)
Number of subjects: 15
Study 35322316 — intervention group
Group type: EXPERIMENTAL
Intervention: Air-abrasive powder
Number of subjects: 60
Study 35322316 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 60
Study 35322316 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma cleaning
Number of subjects: 60
Study 35322316 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrolytic cleaning - Potassium Iodide (KI)
Number of subjects: 60
Study 35322316 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrolytic cleaning - Sodium Formate (CHNaO2)
Number of subjects: 60
Study 35322316 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 60
Study 35758427 — intervention group
Group type: EXPERIMENTAL
Intervention: OpenSound Navigator (OSN)
Number of subjects: 40
Study 35758427 — intervention group
Group type: COMPARATOR
Intervention: Omnidirectional algorithm (OMNI)
Number of subjects: 40
Study 35758427 — intervention group
Group type: EXPERIMENTAL
Intervention: Both OSN and OMNI
Number of subjects: 40
Study 34089660 — intervention group
Group type: EXPERIMENTAL
Intervention: rtCGM
Number of subjects: 254
Study 34089660 — intervention group
Group type: COMPARATOR
Intervention: isCGM
Number of subjects: 254
Study 35234868 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA‐1273
Number of subjects: 412
Study 35234868 — intervention group
Group type: COMPARATOR
Intervention: BNT162b2
Number of subjects: 412
Study 35234868 — intervention group
Group type: COMPARATOR
Intervention: SOTR
Number of subjects: 412
Study 32039955 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinematic alignment
Number of subjects: 99
Study 32039955 — intervention group
Group type: COMPARATOR
Intervention: Mechanical alignment
Number of subjects: 99
Study 2011535125 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedimed cream
Number of subjects: 54
Study 2011535125 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 34532818 — intervention group
Group type: EXPERIMENTAL
Intervention: Phacoemulsification technique
Number of subjects: 0
Study 34532818 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual small incision cataract surgery (MSICS) technique
Number of subjects: 0
Study 34532818 — intervention group
Group type: COMPARATOR
Intervention: Normal cataract cases (G1)
Number of subjects: 0
Study 34532818 — intervention group
Group type: COMPARATOR
Intervention: Complex cataract cases (G2 and G3)
Number of subjects: 0
Study 34532818 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall complication rate
Number of subjects: 0
Study 34735098 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion (150-300 mg/d)
Number of subjects: 26
Study 34735098 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 32573927 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide ER 2 mcg weekly
Number of subjects: 79
Study 32573927 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 35649190 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water hydrotherapy (Kneipp arm affusions) over 6 weeks
Number of subjects: 20
Study 35649190 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study 33839209 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Cognitive Reappraisal (CCR)
Number of subjects: 100
Study 33839209 — intervention group
Group type: COMPARATOR
Intervention: Suppression
Number of subjects: 100
Study 35490395 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib (BARI) 2-4 mg
Number of subjects: 2531
Study 35490395 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2531
Study 35490395 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib (BARI) 2 mg
Number of subjects: 2531
Study 35490395 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib (BARI) 4 mg
Number of subjects: 2531
Study 33864595 — intervention group
Group type: EXPERIMENTAL
Intervention: Male Partner Participation (MPP)
Number of subjects: 535
Study 33864595 — intervention group
Group type: EXPERIMENTAL
Intervention: Male Partner Involvement (MPI)
Number of subjects: 535
Study 33864595 — intervention group
Group type: EXPERIMENTAL
Intervention: Socio-demographic characteristics (educational attainment)
Number of subjects: 535
Study 34385507 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproic acid
Number of subjects: 42
Study 34385507 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 34333143 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 60
Study 34333143 — intervention group
Group type: EXPERIMENTAL
Intervention: Erbium yttrium scandium gallium garnet (Er,Cr:YSGG)
Number of subjects: 60
Study 34333143 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine
Number of subjects: 60
Study 34333143 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 34118259 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane block (ESP) combined with spinal anesthesia (n=16)
Number of subjects: 45
Study 34118259 — intervention group
Group type: COMPARATOR
Intervention: Spinal anesthesia with morphine 1 mcg.kg-1 (n=15)
Number of subjects: 45
Study 34118259 — intervention group
Group type: COMPARATOR
Intervention: Spinal anesthesia (control group, n=14)
Number of subjects: 45
Study 34866163 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect bonded customized CAD/CAM brackets (Insignia™, Ormco, USA)
Number of subjects: 38
Study 34866163 — intervention group
Group type: COMPARATOR
Intervention: Direct bonded self‐ligating brackets (Damon, Ormco, USA)
Number of subjects: 38
Study 34866163 — intervention group
Group type: EXPERIMENTAL
Intervention: Both systems
Number of subjects: 38
Study 34866163 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD/CAM group
Number of subjects: 38
Study 36111620 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain neuroscience education (PNE) and graded exposure
Number of subjects: 37
Study 36111620 — intervention group
Group type: COMPARATOR
Intervention: Pilates and postural education
Number of subjects: 37
Study 32107935 — intervention group
Group type: EXPERIMENTAL
Intervention: Group well-child care (GWCC)
Number of subjects: 97
Study 32107935 — intervention group
Group type: COMPARATOR
Intervention: Individual well-child care (IWCC)
Number of subjects: 97
Study 35066957 — intervention group
Group type: EXPERIMENTAL
Intervention: Education about cervical cancer and Pap smear test (face-to-face interviews using Turkish sign language)
Number of subjects: 156
Study 35066957 — intervention group
Group type: COMPARATOR
Intervention: Control group (no education)
Number of subjects: 156
Study 35066957 — intervention group
Group type: EXPERIMENTAL
Intervention: Education about cervical cancer and Pap smear test
Number of subjects: 156
Study 34343161 — intervention group
Group type: EXPERIMENTAL
Intervention: Early stoma closure (2 weeks)
Number of subjects: 71
Study 34343161 — intervention group
Group type: COMPARATOR
Intervention: Late stoma closure (12 weeks)
Number of subjects: 71
Study 32956008 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidcombe Program without verbal contingencies
Number of subjects: 74
Study 32956008 — intervention group
Group type: COMPARATOR
Intervention: Lidcombe Program with verbal contingencies
Number of subjects: 74
Study 35253721 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific neck stabilization
Number of subjects: 102
Study 35253721 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific core stabilization
Number of subjects: 102
Study 35253721 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined stabilization practices
Number of subjects: 102
Study 33208641 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine (LB) combined with conventional bupivacaine
Number of subjects: 76
Study 33208641 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional bupivacaine combined with dexamethasone)
Number of subjects: 76
Study 33208641 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine with dexamethasone and conventional bupivacaine (LBD group)
Number of subjects: 76
Study 34214736 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractionated HPC infusion (4 × 10^6 CD34+ cells/kg on day 0, remaining cells infused on days 2, 4, and 6)
Number of subjects: 74
Study 34214736 — intervention group
Group type: COMPARATOR
Intervention: Bulk HPC infusion (7 × 10^6 CD34+ cells/kg)
Number of subjects: 74
Study 34214736 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractionated HPC infusion
Number of subjects: 74
Study 34214736 — intervention group
Group type: COMPARATOR
Intervention: Bulk HPC infusion
Number of subjects: 74
Study 35135986 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) 800 mg daily
Number of subjects: 78
Study 35135986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 34959909 — intervention group
Group type: EXPERIMENTAL
Intervention: True information about fluid losses
Number of subjects: 11
Study 34959909 — intervention group
Group type: COMPARATOR
Intervention: False information about fluid losses
Number of subjects: 11
Study 32213013 — intervention group
Group type: EXPERIMENTAL
Intervention: 19-gauge stainless steel needle
Number of subjects: 46
Study 32213013 — intervention group
Group type: EXPERIMENTAL
Intervention: 19-gauge nitinol-based needle
Number of subjects: 46
Study 35642697 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stability exercise program (30 min, in addition to standard physical therapy program)
Number of subjects: 40
Study 35642697 — intervention group
Group type: COMPARATOR
Intervention: Standard physical therapy program (1 h per session, three times weekly)
Number of subjects: 40
Study 34118568 — intervention group
Group type: EXPERIMENTAL
Intervention: SAP block group (n = 43)
Number of subjects: 87
Study 34118568 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 44)
Number of subjects: 87
Study 34118568 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 87
Study 32384874 — intervention group
Group type: EXPERIMENTAL
Intervention: LTBI treatment (specific regimen not detailed)
Number of subjects: 63
Study 32384874 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 63
Study 35549538 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (8-week treatment)
Number of subjects: 89
Study 35549538 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 89
Study 34070321 — intervention group
Group type: EXPERIMENTAL
Intervention: Food insecurity
Number of subjects: 663
Study 32293921 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal glucagon (NG)
Number of subjects: 65
Study 32293921 — intervention group
Group type: COMPARATOR
Intervention: Injectable glucagon (IG)
Number of subjects: 65
Study 33991554 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-controlled volume guaranteed mode (Group PCVG)
Number of subjects: 30
Study 33991554 — intervention group
Group type: COMPARATOR
Intervention: Volume-controlled mode (Group VC)
Number of subjects: 30
Study 33772825 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin prophylaxis
Number of subjects: 117
Study 33772825 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 117
Study 34360103 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stabilization exercise with abdominal drawing-in maneuver technique (CSE with ADIM)
Number of subjects: 34
Study 34360103 — intervention group
Group type: COMPARATOR
Intervention: General strengthening exercise (STE)
Number of subjects: 34
Study 36375341 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Stress Management (CBSM)
Number of subjects: 256
Study 36375341 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation (PE)
Number of subjects: 256
Study 33387391 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D video glasses
Number of subjects: 141
Study 33387391 — intervention group
Group type: EXPERIMENTAL
Intervention: VR glasses
Number of subjects: 141
Study 33387391 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 141
Study 36008895 — intervention group
Group type: EXPERIMENTAL
Intervention: Gouty Tea, 1 bag/time, tid, for 12 weeks
Number of subjects: 120
Study 36008895 — intervention group
Group type: COMPARATOR
Intervention: Allopurinol orally, 100 mg/time, tid, for 12 weeks
Number of subjects: 120
Study 32273085 — intervention group
Group type: EXPERIMENTAL
Intervention: High Velocity Nasal Insufflation (HVNI)
Number of subjects: 65
Study 32273085 — intervention group
Group type: COMPARATOR
Intervention: Non-Invasive Positive Pressure Ventilation (NIPPV)
Number of subjects: 65
Study 34569480 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal retraining (training group)
Number of subjects: 345
Study 34569480 — intervention group
Group type: COMPARATOR
Intervention: No training (no-training group)
Number of subjects: 345
Study 32174297 — intervention group
Group type: EXPERIMENTAL
Intervention: Helping Families Programme‐Modified
Number of subjects: 48
Study 32174297 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 48
Study 32174297 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 48
Study 35339323 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Orientation to daily Occupational Performance (CO‐OP) with traditional rehabilitation
Number of subjects: 20
Study 35339323 — intervention group
Group type: COMPARATOR
Intervention: Traditional rehabilitation
Number of subjects: 20
Study 36229155 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Habits Triple P - Oral health (web-based parenting intervention)
Number of subjects: 18
Study 36229155 — intervention group
Group type: COMPARATOR
Intervention: Control group (oral health-related information published by Australian oral health agencies)
Number of subjects: 18
Study 34167929 — intervention group
Group type: EXPERIMENTAL
Intervention: His‐CRT
Number of subjects: 50
Study 34167929 — intervention group
Group type: COMPARATOR
Intervention: BiV‐CRT
Number of subjects: 50
Study 32228315 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib (600 mg orally daily in 2 divided doses, 400 and 200 mg) and cyclophosphamide (50 mg orally daily for 21 days every 28 days)
Number of subjects: 20
Study 33523907 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic risk score approach
Number of subjects: 78500
Study 33523907 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomic risk mapping
Number of subjects: 78500
Study 33523907 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-sample Mendelian randomization
Number of subjects: 78500
Study 34520104 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise + Protein (EP)
Number of subjects: 100
Study 34520104 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein (P)
Number of subjects: 100
Study 34520104 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 100
Study 34520104 — intervention group
Group type: COMPARATOR
Intervention: Exercise (E)
Number of subjects: 100
Study 32926573 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine + Azithromycin
Number of subjects: 377
Study 32926573 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine alone
Number of subjects: 377
Study 32926573 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 377
Study 34922567 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered acupressure plus rescue medication (RM)
Number of subjects: 41
Study 34922567 — intervention group
Group type: COMPARATOR
Intervention: Rescue medication (RM) alone
Number of subjects: 41
Study 32764634 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral probiotic lozenges containing Streptococcus salivarius M18
Number of subjects: 13
Study 32764634 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 33998292 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (60 min at 65% VO2max)
Number of subjects: 12
Study 32555211 — intervention group
Group type: EXPERIMENTAL
Intervention: Comfort blankets (tactile enrichment)
Number of subjects: 120
Study 32555211 — intervention group
Group type: EXPERIMENTAL
Intervention: Music (auditory enrichment)
Number of subjects: 120
Study 32555211 — intervention group
Group type: EXPERIMENTAL
Intervention: Paro robot (multi-sensory enrichment)
Number of subjects: 120
Study 32555211 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 34545437 — intervention group
Group type: EXPERIMENTAL
Intervention: Laterally closed tunnel technique + photobiomodulation (660 nm diode, 3.5 J/cm2 per point)
Number of subjects: 19
Study 34545437 — intervention group
Group type: EXPERIMENTAL
Intervention: Laterally closed tunnel technique + photobiomodulation
Number of subjects: 19
Study 34545437 — intervention group
Group type: COMPARATOR
Intervention: Laterally closed tunnel technique + sham laser
Number of subjects: 19
Study 33779057 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine as prophylaxis for COVID-19
Number of subjects: 0
Study 33048300 — intervention group
Group type: EXPERIMENTAL
Intervention: Itolizumab
Number of subjects: 30
Study 33048300 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 35964061 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program
Number of subjects: 200
Study 35964061 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 200
Study 34312191 — intervention group
Group type: EXPERIMENTAL
Intervention: Tipping Point Programme (TPP)
Number of subjects: 1242
Study 34312191 — intervention group
Group type: EXPERIMENTAL
Intervention: TPP+ with emphasised social norms change
Number of subjects: 1242
Study 34312191 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1242
Study 33207935 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin (16 mg/day, with a 2-week titration)
Number of subjects: 100
Study 33207935 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 33207935 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 100
Study 35843465 — intervention group
Group type: EXPERIMENTAL
Intervention: His-bundle pacing (HBP)
Number of subjects: 50
Study 35843465 — intervention group
Group type: COMPARATOR
Intervention: Biventricular pacing (BVP)
Number of subjects: 50
Study 35843465 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HBP and BVP
Number of subjects: 50
Study 32306083 — intervention group
Group type: EXPERIMENTAL
Intervention: High-precision image-guided single-session radiosurgery with 25 Gy
Number of subjects: 20
Study 35148195 — intervention group
Group type: EXPERIMENTAL
Intervention: YES-10 (200 mg, 2 capsules daily for 4 weeks)
Number of subjects: 72
Study 35148195 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 capsules daily for 4 weeks)
Number of subjects: 72
Study 33004235 — intervention group
Group type: EXPERIMENTAL
Intervention: Care Consultation
Number of subjects: 445
Study 35143970 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 82
Study 35143970 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise
Number of subjects: 82
Study 35143970 — intervention group
Group type: COMPARATOR
Intervention: Wait-list Control
Number of subjects: 82
Study 33549836 — intervention group
Group type: EXPERIMENTAL
Intervention: FRUIT+DGV smoothie condition
Number of subjects: 68
Study 33549836 — intervention group
Group type: COMPARATOR
Intervention: FRUIT ONLY smoothie condition
Number of subjects: 68
Study 36341230 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint catgut embedding (ACE) for strong appetite group
Number of subjects: 123
Study 36341230 — intervention group
Group type: COMPARATOR
Intervention: Control (non-acupoint catgut embedding) for strong appetite group
Number of subjects: 123
Study 36341230 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint catgut embedding (ACE) for moderate appetite group
Number of subjects: 123
Study 36341230 — intervention group
Group type: COMPARATOR
Intervention: Control (non-acupoint catgut embedding) for moderate appetite group
Number of subjects: 123
Study 32009286 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0
Study 32009286 — intervention group
Group type: COMPARATOR
Intervention: Newer glucose-lowering medications (sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists)
Number of subjects: 0